![Foto de Fabrizio](/img/nophoto.png)
Fabrizio
D'Ascenzo
Publicacións nas que colabora con Fabrizio D'Ascenzo (40)
2024
-
Corrigendum to ‘Forecasting the Risk of Heart Failure Hospitalization After Acute Coronary Syndromes: the CORALYS HF Score’ [American Journal of Cardiology 206 (2023) 320-329, (S000291492300766X), (10.1016/j.amjcard.2023.08.010)]
American Journal of Cardiology
-
Gender differences in the development of heart failure after acute coronary syndrome: Insight from the CORALYS registry
International Journal of Cardiology, Vol. 397
2023
-
Forecasting the Risk of Heart Failure Hospitalization After Acute Coronary Syndromes: the CORALYS HF Score
American Journal of Cardiology, Vol. 206, pp. 320-329
-
Impact of Complete Revascularization on Development of Heart Failure in Patients With Acute Coronary Syndrome and Multivessel Disease: A Subanalysis of the CORALYS Registry
Journal of the American Heart Association, Vol. 12, Núm. 15, pp. e028475
-
Impact of Right Ventricular Pacing in Patients With TAVR Undergoing Permanent Pacemaker Implantation
JACC: Cardiovascular Interventions, Vol. 16, Núm. 9, pp. 1081-1091
-
IncidenCe and predictOrs of heaRt fAiLure after acute coronarY Syndrome: The CORALYS registry
International Journal of Cardiology, Vol. 370, pp. 35-42
-
Optimal medical therapy improves outcomes in patients with diabetes mellitus and acute myocardial infarction
Diabetes Research and Clinical Practice, Vol. 203
2022
-
Ischemic-hemorrhagic balance in diabetic and non-diabetic patients after acute coronary syndrome
REC: CardioClinics, Vol. 57, Núm. 3, pp. 203-211
-
Safety and efficacy of different P2Y12 inhibitors in patients with acute coronary syndromes stratified by the PRAISE risk score: a multicentre study
European heart journal. Quality of care & clinical outcomes, Vol. 8, Núm. 8, pp. 881-891
2021
-
Evaluation of optimal medical therapy in acute myocardial infarction patients with prior stroke
Therapeutic Advances in Chronic Disease, Vol. 12
-
Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets
The Lancet, Vol. 397, Núm. 10270, pp. 199-207
-
Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational Registries
Cardiovascular Drugs and Therapy, Vol. 35, Núm. 6, pp. 1171-1182
-
Ticagrelor versus prasugrel in acute coronary syndrome: sex-specific analysis from the RENAMI Registry
Minerva cardiology and angiology, Vol. 69, Núm. 4, pp. 408-416
2020
-
Antithrombotic Therapy in Patients With Prior Stroke/Transient Ischemic Attack and Acute Coronary Syndromes
Angiology
-
Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registries
American Heart Journal, Vol. 220, pp. 108-115
-
Impact of renin-angiotensin system blockade on the prognosis of acute coronary syndrome based on left ventricular ejection fraction
Revista espanola de cardiologia (English ed.), Vol. 73, Núm. 2, pp. 114-122
-
Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry
European Journal of Preventive Cardiology, Vol. 27, Núm. 7, pp. 696-705
-
Outcomes of acute coronary syndromes in coronavirus disease 2019
Clinical Research in Cardiology
-
P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects
European heart journal. Cardiovascular pharmacotherapy, Vol. 6, Núm. 1, pp. 31-42
-
The impact of optimal medical therapy on patients with recurrent acute myocardial infarction: Subanalysis from the BleeMACS study
International Journal of Cardiology, Vol. 318, pp. 1-6